MedTrace Logo

A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis

NCT04771728 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2025-06-12

No results posted yet for this study

Summary

The investigators are trying to determine if oral Probiotics(Umeta-mimi,30 days) with Metronidazole vaginal suppositories (7 days) is better than using Metronidazole vaginal suppositories(7 days) only in preventing the recurrence of bacterial vaginosis

Conditions

  • Bacterial Vaginosis

Interventions

DRUG

Metronidazole vaginal suppositories

Metronidazole vaginal suppositories (200 mg,2 capsules per day,7 days )

DRUG

Metronidazole vaginal suppositories and Probiotics(Umeta-mimi)

Metronidazole vaginal suppositories (200 mg,2 capsules per day,7 days ) and Oral pobiotics(Umeta-mimi,5×109cfu per day,30 days）

Sponsors & Collaborators

  • BGI, China

    collaborator OTHER

  • Peking University Shenzhen Hospital

    lead OTHER

Principal Investigators

  • Ruifang Wu, M.D. · Dept of Obstetrics and Gynecology,Peking University Shenzhen Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2026-12-01
Completion
2026-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04771728 on ClinicalTrials.gov